These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11221496)

  • 1. Combination risperidone and quetiapine therapy in refractory schizophrenia.
    Chue P; Welch R; Snaterse M
    Can J Psychiatry; 2001 Feb; 46(1):86-7. PubMed ID: 11221496
    [No Abstract]   [Full Text] [Related]  

  • 2. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia.
    Perez V; Cañas F; Tafalla M;
    Int Clin Psychopharmacol; 2008 May; 23(3):138-49. PubMed ID: 18408528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiaggressive action of combined risperidone and quetiapine in a patient with schizophrenia.
    Bozikas VP; Deseri C; Pitsavas S; Karavatos A
    Can J Psychiatry; 2003 Jul; 48(6):426-7. PubMed ID: 12894620
    [No Abstract]   [Full Text] [Related]  

  • 4. Quetiapine: efficacy, tolerability and safety in schizophrenia.
    Miodownik C; Lerner V
    Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical guidelines: Dosing and switching strategies for long-acting risperidone.
    Marder SR; Conley R; Ereshefsky L; Kane JM; Turner MS
    J Clin Psychiatry; 2003; 64 Suppl 16():41-6. PubMed ID: 14680418
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between antipsychotic combination therapy and treatment adherence among individuals with bipolar disorder.
    Gianfrancesco FD; Sajatovic M; Tafesse E; Wang RH
    Ann Clin Psychiatry; 2009; 21(1):3-16. PubMed ID: 19239828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent constipation with higher doses of quetiapine: a case series.
    Raedler TJ; Reimer J; Wiedemann K
    Int Clin Psychopharmacol; 2007 Jul; 22(4):244-6. PubMed ID: 17519649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal prolactin elevation in a schizophrenic patient in treatment with quetiapine and mirtazapine. The role of opioid system.
    Orlandi V; Speca A; Salviati M; Biondi M
    J Clin Psychopharmacol; 2003 Dec; 23(6):677-9. PubMed ID: 14624206
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of warm-supplementing kidney yang (WSKY) capsule added on risperidone on cognition in chronic schizophrenic patients: a randomized, double-blind, placebo-controlled, multi-center clinical trial.
    Chen ZH; Wang GH; Wang XP; Chen RY; Wang HL; Yang MH; Huo YX; Mei HB
    Hum Psychopharmacol; 2008 Aug; 23(6):465-70. PubMed ID: 18536066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Administration of once-daily extended release quetiapine in schizophrenic disorders].
    Bartkó G
    Neuropsychopharmacol Hung; 2007 Dec; 9(4):189-95. PubMed ID: 18510263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial.
    Byerly MJ; Nakonezny PA; Rush AJ
    Psychiatry Res; 2008 May; 159(1-2):115-20. PubMed ID: 18295343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning.
    Knegtering R; Castelein S; Bous H; Van Der Linde J; Bruggeman R; Kluiter H; van den Bosch RJ
    J Clin Psychopharmacol; 2004 Feb; 24(1):56-61. PubMed ID: 14709948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacology news.
    Silva R
    J Child Adolesc Psychopharmacol; 2009 Feb; 19(1):91. PubMed ID: 19232027
    [No Abstract]   [Full Text] [Related]  

  • 15. Does quetiapine have mood altering properties?
    Mishra A; Moore PB; Hobbs R
    J Psychopharmacol; 2004 Jun; 18(2):281-4. PubMed ID: 15260919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic schizophrenia. Options for pharmacologic management.
    Pary R; Tobias CR; Lippmann S
    Postgrad Med; 1995 Nov; 98(5):163-4, 167-70, 173. PubMed ID: 7479452
    [No Abstract]   [Full Text] [Related]  

  • 17. A change from risperidone long acting injection to paliperidone palmitate in an elderly patient--a cautionary tale.
    Singh D; Williams O
    Aust N Z J Psychiatry; 2012 Feb; 46(2):176-7. PubMed ID: 22311537
    [No Abstract]   [Full Text] [Related]  

  • 18. The effectiveness of the combination therapy of amisulpride and quetiapine for managing treatment-resistant schizophrenia: a naturalistic study.
    Quintero J; Barbudo E; Molina JD; Mur C; Ceverino A; Garcia-Resa E; Correas Lauffer J
    J Clin Psychopharmacol; 2011 Apr; 31(2):240-2. PubMed ID: 21364334
    [No Abstract]   [Full Text] [Related]  

  • 19. Donepezil for memory dysfunction in schizophrenia.
    Howard AK; Thornton AE; Altman S; Honer WG
    J Psychopharmacol; 2002 Sep; 16(3):267-70. PubMed ID: 12236636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended release quetiapine fumarate and pregnancy.
    Tényi T; Nagy Á; Herold R; Fekete S
    Neuropsychopharmacol Hung; 2013 Mar; 15(1):49-50. PubMed ID: 23542759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.